Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $82.26 | 2 | 73.8% |
| Education | $29.26 | 2 | 26.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $82.26 | 2 | $0 (2019) |
| PFIZER INC. | $29.26 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $70.43 | 3 | Astellas Pharma US Inc ($41.17) |
| 2017 | $41.09 | 1 | Astellas Pharma US Inc ($41.09) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/27/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 05/03/2019 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $41.17 | General |
| 01/03/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $41.09 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,049 | 1,415 | $313,405 | $90,740 |
| 2022 | 12 | 1,148 | 1,556 | $267,934 | $88,178 |
| 2021 | 14 | 1,409 | 1,937 | $307,667 | $105,319 |
| 2020 | 18 | 2,468 | 3,828 | $548,638 | $188,126 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 315 | 445 | $71,200 | $26,591 | 37.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 104 | 137 | $78,501 | $21,173 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 105 | $23,940 | $8,794 | 36.7% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 14 | 14 | $34,482 | $7,521 | 21.8% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 14 | 14 | $23,100 | $6,111 | 26.5% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 24 | 24 | $16,800 | $3,956 | 23.5% |
| 52281 | Dilation of urethra using an endoscope | Office | 2023 | 16 | 16 | $12,528 | $3,760 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $9,145 | $3,092 | 33.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 33 | $8,316 | $3,001 | 36.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 23 | 23 | $8,740 | $2,302 | 26.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 16 | 17 | $16,541 | $1,564 | 9.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 324 | 508 | $4,064 | $1,114 | 27.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $3,920 | $1,112 | 28.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 14 | $1,386 | $542.75 | 39.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 14 | 14 | $742.00 | $106.26 | 14.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 384 | 557 | $88,560 | $31,135 | 35.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 90 | 132 | $75,636 | $22,364 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 154 | $35,013 | $13,097 | 37.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $13,570 | $5,552 | 40.9% |
| 52281 | Dilation of urethra using an endoscope | Office | 2022 | 15 | 15 | $11,745 | $3,610 | 30.7% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2022 | 13 | 16 | $13,504 | $3,310 | 24.5% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 15 | 15 | $10,500 | $2,569 | 24.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $4,032 | $1,606 | 39.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 36 | 38 | $3,742 | $1,336 | 35.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 12 | 12 | $4,560 | $1,235 | 27.1% |
About Dr. Izzuddin Mansur, M.D
Dr. Izzuddin Mansur, M.D is a Urology healthcare provider based in Crossville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508828344.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Izzuddin Mansur, M.D has received a total of $111.52 in payments from pharmaceutical and medical device companies, with $70.43 received in 2019. These payments were reported across 4 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($82.26).
As a Medicare-enrolled provider, Mansur has provided services to 6,074 Medicare beneficiaries, totaling 8,736 services with total Medicare billing of $472,363. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Crossville, TN
- Active Since 04/05/2006
- Last Updated 06/14/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508828344
Products in Payments
- Xtandi (Drug) $41.09
- XTANDI (Drug) $29.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.